Thumbnail Image
Publication

Pembrolizumab with or without chemotherapy vs chemotherapy in patients with advanced G/GEJ cancer (GC) including outcomes according to Microsatellite Instability-High (MSI-H) status in KEYNOTE-062

Shitara, K
; 
Van Cutsem, E
; 
Bang, YJ
; 
Fuchs, CS
; 
Wyrwicz, L
; 
Lee, KW
; 
Kudaba, I
; 
Garrido, M
; 
Chung, HC
; 
Castro, HR
... show 9 more
Citations
Altmetric:
Abstract
Authors
Shitara, K
Van Cutsem, E
Bang, YJ
Fuchs, CS
Wyrwicz, L
Lee, KW
Kudaba, I
Garrido, M
Chung, HC
Castro, HR
Mansoor, Was
Braghiroli, MIFM
Goekkurt, E
Chao, J
Wainberg, ZA
Kher, U
Shah, S
Kang, SP
Tabernero, J
Affiliation
Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
Description
Date
2019
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL. Conference abstract
Adobe PDF, 87.49 KB
Keywords
Type
Meetings and Proceedings
Citation
Shitara K, Van Cutsem E, Bang YJ, Fuchs CS, Wyrwicz L, Lee KW, et al. LBA44Pembrolizumab with or without chemotherapy vs chemotherapy in patients with advanced G/GEJ cancer (GC) including outcomes according to Microsatellite Instability-High (MSI-H) status in KEYNOTE-062. Annals of Oncology. 2019;30(Supplement_5):878.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622598
Embedded videos